---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-047855"
form_type: "8-K"
ticker: "INTS"
cik: "0001567264"
company_name: "INTENSITY THERAPEUTICS, INC."
filed_at: "2025-10-31T23:59:59+00:00"
generated_at: "2026-05-17T01:06:32.880795+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Intensity Therapeutics prices $4M registered direct offering of 5M shares at $0.80

## Summary
- Gross proceeds of $4.0M from sale of 5M shares at $0.80 per share; closing expected Nov 3, 2025.
- Net proceeds to fund clinical trial advancement, working capital, and general corporate purposes.
- Cash runway expected to extend to end of Q1 2027 after the offering closes.
- A.G.P./Alliance Global Partners is sole placement agent; fee 7% of gross proceeds plus up to $50k expenses.

## SEC filing metadata
- accession: 0001628280-25-047855
- form_type: 8-K
- ticker: INTS
- cik: 0001567264
- company_name: INTENSITY THERAPEUTICS, INC.
- filed_at: 2025-10-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1567264/000162828025047855/0001628280-25-047855-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1567264/000162828025047855/intensity-20251030.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-047855
- JSON: https://secwatch.observer/filing/0001628280-25-047855.json
- Plain text: https://secwatch.observer/filing/0001628280-25-047855.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.